TG Therapeutics, Inc.
TGTX
$42.54
-$0.60-1.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 461.90M | 447.18M | 447.47M | 60.46M | 39.15M |
| Total Depreciation and Amortization | 83.00K | 59.00K | 47.00K | 41.00K | 47.00K |
| Total Amortization of Deferred Charges | 1.38M | 1.40M | 1.41M | 1.53M | 1.87M |
| Total Other Non-Cash Items | -261.55M | -278.87M | -308.27M | 56.70M | 49.68M |
| Change in Net Operating Assets | -215.76M | -194.54M | -210.73M | -177.85M | -151.77M |
| Cash from Operations | -13.95M | -24.77M | -70.07M | -59.13M | -61.03M |
| Capital Expenditure | -240.00K | -214.00K | -168.00K | -112.00K | -70.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.11M | 14.01M | 45.39M | -10.36M | -4.65M |
| Cash from Investing | 16.87M | 13.80M | 45.23M | -10.47M | -4.72M |
| Total Debt Issued | 747.66M | -- | 0.00 | 244.82M | 244.82M |
| Total Debt Repaid | -255.00M | -- | 0.00 | -107.55M | -107.55M |
| Issuance of Common Stock | 2.25M | 1.51M | 1.02M | 1.22M | 925.00K |
| Repurchase of Common Stock | -185.11M | -91.24M | -97.85M | -21.76M | -14.88M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.60M | -- | -31.00K | -889.00K | -889.00K |
| Cash from Financing | 307.20M | -89.73M | -96.86M | 115.84M | 122.42M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 310.12M | -100.70M | -121.71M | 46.24M | 56.68M |